entertainment -WSS

entertainment

author：hotspot 2025-09-27 22:18:31 - browse：64

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How one medical school became remarkably diverse
Next article： FTX founder Sam Bankman

WSS

ADCs take center stage as promising cancer treatments

‘The Bear’ and hospitality in hospitals

STAT Summit: How researchers deal with rejection

Sage's campaign to raise awareness of postpartum depression hits a nerve

‘The Bear’ and hospitality in hospitals

Roivant's CEO is a star, but biotech's black hole persists

entertainment

entertainment

leisure time

Activists slam private health insurers over coverage restrictions

Choosing scientific sides in the fight against Alzheimer's

Hepatitis C has a cure — but many Americans still lack access to it

The painfully weak evidence on taking collagen to treat arthritis

Medicare proposal to cover medical devices draws a mixed reaction

In venture capital firm's success, lessons for turning crisis into profit

Psychedelics group wrestles with new pharma identity

Ohioans vote in high

Duchenne breakthrough therapy leaves behind pioneering families

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

hotspot

In venture capital firm's success, lessons for turning crisis into profit

Wegovy cuts risk of cardiovascular events by 20%, study finds

‘The Bear’ and hospitality in hospitals

‘The Bear’ and hospitality in hospitals

FTX founder Sam Bankman

Roche drug slashes death risk in early

knowledge

entertainment

focus

focus